Biophytis Proposes Reverse Stock Split of Up to 100 Shares for One

• Biophytis shareholders will vote November 12, 2026, on capital-raising authorizations of up to EUR 38 million each.
• Issuances without preemptive rights could carry discounts up to 25%; private placements would be capped at 30% of capital annually.
• Capital restructuring proposals include a reverse split of up to 100-for-1 and reducing shares’ nominal value to no less than EUR 0.001.
• A proposed 18-month buyback would cover up to 37,387,538 shares, or 10% of capital, at a maximum EUR 0.10 per share.
• Shareholders will also consider renewing director Jean Mariani’s mandate for three years, through the 2029 annual meeting.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biophytis SA published the original content used to generate this news brief on October 19, 2026, and is solely responsible for the information contained therein.